RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cell Kinetics Stock

Cell Kinetics P/E 2024

Cell Kinetics P/E

-10.17

Ticker

CKNTF

ISIN

IL0011098758

WKN

A0MV4W

As of Nov 18, 2024, Cell Kinetics's P/E ratio was -10.17, a 0% change from the 0 P/E ratio recorded in the previous year.

The Cell Kinetics P/E history

Cell Kinetics Aktienanalyse

What does Cell Kinetics do?

Cell Kinetics Ltd is a company specializing in the research and production of cell therapy products. The company was founded in 2020 and is based in London, United Kingdom. Cell Kinetics Ltd has a visionary mission that inspires the company to discover and develop groundbreaking solutions to improve people's health and well-being. The company aims to research, develop, and deliver therapies for serious diseases such as cancer and neurodegenerative disorders. The business model of Cell Kinetics Ltd is based on comprehensive research of new cell therapies and collaboration with academic partners to validate the clinical benefits of these therapies. The company has established partnerships with leading academic institutions and medical centers in Europe and the USA. Cell Kinetics Ltd works in various areas to achieve the goal of discovering and developing new therapies for serious diseases. An important focus of the company is the development of cell culture methods for the production and maintenance of therapeutic cells in large quantities. The company has extensive experience in developing artificial platforms for cell cultivation, including bioreactor-based cultivation, single-cell-sensitive cultivation, and the use of chemicals for cell cultivation. Another focus of Cell Kinetics Ltd is the development of carcinoma therapies. The company has developed a special technology for the production of T-cells that can be used to kill cancer cells. These T-cells are obtained from blood samples of cancer patients and cultivated in vitro. The company has also developed a technology that allows these T-cells to be modified to fight deadly diseases such as leukemia and lymphoma. Another focus of Cell Kinetics Ltd is the development of therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. The company is developing special technologies to differentiate neural stem cells that can serve as a therapeutic tool for the treatment of these diseases. These neural stem cells can be used to repair damaged nerve cells. Cell Kinetics Ltd is proud to offer a range of products that can contribute to improving the health and well-being of patients. The company offers therapy products for cancer treatment, neurodegenerative diseases, and cardiovascular diseases, among others. In addition, the company also provides a wide range of services, including the development and production of cell therapy products, as well as artificial platforms for cell cultivation. Overall, Cell Kinetics Ltd has become a major player in the field of cell therapy and the development of therapies for serious diseases. The company is committed to continuing to develop groundbreaking discoveries and technologies to improve the lives of millions of people around the world. Cell Kinetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Cell Kinetics's P/E Ratio

The Price to Earnings (P/E) Ratio of Cell Kinetics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Cell Kinetics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Cell Kinetics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Cell Kinetics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Cell Kinetics stock

What is the price-to-earnings ratio of Cell Kinetics?

The price-earnings ratio of Cell Kinetics is currently -10.17.

How has the price-earnings ratio of Cell Kinetics changed compared to last year?

The price-to-earnings ratio of Cell Kinetics has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Cell Kinetics high compared to other companies?

Yes, the price-to-earnings ratio of Cell Kinetics is high compared to other companies.

How does an increase in the price-earnings ratio of Cell Kinetics affect the company?

An increase in the price-earnings ratio of Cell Kinetics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Cell Kinetics affect the company?

A decrease in the price-earnings ratio of Cell Kinetics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Cell Kinetics?

Some factors that influence the price-earnings ratio of Cell Kinetics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Cell Kinetics pay?

Over the past 12 months, Cell Kinetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cell Kinetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Cell Kinetics?

The current dividend yield of Cell Kinetics is .

When does Cell Kinetics pay dividends?

Cell Kinetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cell Kinetics?

Cell Kinetics paid dividends every year for the past 0 years.

What is the dividend of Cell Kinetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cell Kinetics located?

Cell Kinetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cell Kinetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cell Kinetics from 11/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Cell Kinetics pay the last dividend?

The last dividend was paid out on 11/18/2024.

What was the dividend of Cell Kinetics in the year 2023?

In the year 2023, Cell Kinetics distributed 0 USD as dividends.

In which currency does Cell Kinetics pay out the dividend?

The dividends of Cell Kinetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cell Kinetics

Our stock analysis for Cell Kinetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cell Kinetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.